Publication | Closed Access
Susceptibility of Campylobacter species to nalidixic acid, enoxacin, and other DNA gyrase inhibitors
54
Citations
16
References
1985
Year
Antimicrobial ChemotherapyAntibiotic ResistanceDrug ResistanceC. ColiCampylobacter InfectionsNalidixic AcidInhibitory ActivityAntimicrobial ResistanceHealth SciencesC. Fetus SubspAntibacterial AgentAntimicrobial CompoundPharmacologyClinical MicrobiologyCampylobacter SpeciesNalidixic Acid-resistant MutantsAntimicrobial Resistance GeneAntimicrobial SusceptibilityMicrobiologyMedicine
Nalidixic acid-resistant mutants of Campylobacter jejuni and C. coli as well as "C. laridis" strains showed cross-resistance to another DNA gyrase subunit A inhibitor, enoxacin (MIC, 32 micrograms/ml), whereas C. fetus subsp. fetus, C. fetus subsp. venerealis, and "C. hyointestinalis" strains were all susceptible to enoxacin (MIC, less than or equal to 2 micrograms/ml). All Campylobacter species were resistant to novobiocin (MIC, 32 to 512 micrograms/ml), but most strains were susceptible to the other DNA gyrase subunit B inhibitors coumermycin A1 and clorobiocin.
| Year | Citations | |
|---|---|---|
Page 1
Page 1